PHA Canada's very own Dr. Sanjay Metha, Dr. Lisa Mielniczuk, and others have published a study in the European Respiratory Review. Read about their systemic review of PAH medications here.
top of page
Recent Posts
The ZENITH study examined whether adding sotatercept to people's ongoing therapies reduced the risk of death, lung transplantation, or...
Great news for the Pulmonary Hypertension (PH) community! Through the Canadian Drug Agency's (CDA) funding initiative for rare diseases,...
As most PH clinics are in large cities, PH patients living in rural or remote areas and who must travel long distances to their clinic...
bottom of page
コメント